盐酸氨溴索辅佐阿奇霉素治疗儿童肺炎支原体肺炎的疗效分析

doi:10.3969/j.issn.1006-6233.2017.11.041

摘要
图/表
参考文献
相关文章 (3)

全文: PDF (1338 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要 目的: 探讨盐酸氨溴索辅佐阿奇霉素治疗儿童肺炎支原体肺炎的疗效。方法: 收集2015年4月至2017年4月200例肺炎支原体肺炎患儿随机分为两组,对照组患儿给予阿奇霉素,实验组患儿则加用盐酸氨溴索,比较两组患儿相关临床指标、总体治疗效果、实验室指标、肺功能、凝血指标与免疫功能。结果: 实验组患儿退热时间、咳嗽消失时间、啰音消失时间、X线浸润影消失时间与住院时间均显著性低于对照组;治疗后CRP、D-二聚体、IL-4、FIB与IgE水平组间比较均显著性低于对照组,FVC、FEV₁、PEF、FEF₇₅、IgA与IgG水平均显著性高于对照组,存在显著性差异(P<0.01);痊愈率明显高于对照组,存在明显差异(P<0.05)。结论: 盐酸氨溴索辅佐阿奇霉素治疗儿童肺炎支原体肺炎的疗效显著,具有借鉴意义。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	王潇娉

关键词 ：盐酸氨溴索, 阿奇霉素, 肺炎支原体肺炎

Abstract：Objective: To investigate the efficacy of ambroxol hydrochloride and azithromycin in the treatment of mycoplasmal pneumonia in children. Methods: From April 2015 to April 2017, 200 cases of Mycoplasma pneumoniae pneumonia were randomly divided into two groups. The children in the control group were given azithromycin. The children in the experimental group were treated with ambroxol hydrochloride, Group of clinical indicators, the overall treatment effect, laboratory indicators, pulmonary function, coagulation index and immune function. Results: The time of fever, the time of disappearance of cough, the disappearance of rales and the time of disappearance of X-ray infiltration were significantly lower than those of the control group. After treatment, CRP, D-dimer, IL-4, FGF, FEV1, PEF, FEF75, IgA and IgG were significantly higher than those in the control group (P <0.01). The cure rate was significantly higher than that of the control group In the control group, there were significant differences (P <0.05). Conclusion: Ambroxol hydrochloride combined with azithromycin has a significant effect in the treatment of mycoplasma pneumoniae pneumonia in children.

Key words： Ambroxol hydrochloride Azithromycin Mycoplasma pneumoniae pneumonia

基金资助:广东省科技计划项目,(编号:2013B0332)

引用本文:

王潇娉. 盐酸氨溴索辅佐阿奇霉素治疗儿童肺炎支原体肺炎的疗效分析[J]. 河北医学, 2017, 23(11): 1898-1900.
WANG Xiaoping. Efficacy of Ambroxol Hydrochloride and Azithromycin in the Treatment of Mycoplasmal Pneumonia in Children. HeBei Med, 2017, 23(11): 1898-1900.

链接本文:

http://www.hbyxzzs.cn/CN/10.3969/j.issn.1006-6233.2017.11.041 或 http://www.hbyxzzs.cn/CN/Y2017/V23/I11/1898

[1] 黄玉玲.甲基泼尼松龙辅助阿奇霉素对儿童支原体肺炎急性发作的疗效研究[J].河北医药,2016,38(19):2905~2907.
[2] 熊寒梅,潘冬妮,周兴美,等.阿奇霉素治疗儿童支原体肺炎的效果观察[J].西部医学,2013,25(5):721~722.
[3] 王法红,魏本松.阿奇霉素联合盐酸氨溴索治疗肺炎支原体肺炎的效果及对IL-10、TNF-α的影响[J].国际医药卫生导报,2016,22(14):2111~2114.
[4] 邵肖梅,叶鸿瑁,丘小汕.实用儿科学[M].第4版.北京.人民卫生出版社,2011.832~840.
[5] Shan L S,Liu X,Kang X Y,et al.Effects of methylprednisolone or immunoglobulin when added to standard treatment with intravenous azithromycin for refractory mycoplasma pneumoniae pneumonia in children[J].World Pediatr,2017.
[6] 符改梅.盐酸氨溴索辅佐阿奇霉素治疗100例儿童肺炎支原体肺炎的临床效果观察[J].黑龙江医药,2015,28(4):796~797.
[7] 刘秋海,袁辉云,胡凌伟.阿奇霉素注射液治疗儿童重症支原体肺炎46例疗效观察[J].浙江中西医结合杂志,2011,21(2):120~121.
[8] 张玲.红霉素-阿奇霉素序贯治疗儿童支原体肺炎的疗效分析[J].中国妇幼保健,2013,28(26):4393~4395.
[9] Ishiguro N,Koseki N,Kaiho M,et al.Therapeutic efficacy of azithromycin,clarithromycin,minocycline and tosufloxacin against macrolide-resistant and macrolide-sensitive mycoplasma pneumoniae pneumonia in pediatric patients[J].PLoS One,2017,12(3):e173635.
[10] 刘学斌.阿奇霉素与盐酸氨溴索联用对儿童支原体肺炎患者的临床疗效评价[J].抗感染药学,2015,12(5):788~789.
[11] 陈霞,崔喜英,董凤龙,等.阿奇霉素序贯疗法联合盐酸氨溴索治疗儿童支原体肺炎41例[J].中国药业,2015,24(13):96~97.
[12] 仇成凤,谭力铭.两种阿奇霉素序贯治疗方案治疗儿童支原体肺炎的疗效比较[J].中国药房,2013,24(48):4557~4559.